PorTal Access secures FDA clearance for vascular access ports

▤ Summary

PorTal Access has received FDA clearance for its FLEXI-PORT family of implantable vascular access ports. The devices are designed to give patients long-term bloodstream access with less discomfort than rigid ports and fewer needle pricks for IV treatment or blood draws. The company says the solution is intended for adult and pediatric use across multiple clinical settings. After clearance, PorTal plans to expand commercialization in the US and work more closely with providers, health systems, partners, and distributors while training clinicians on safe use.

▦ Linked Companies